English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, July 26, 2022
노보텍의 유연 근무 정책, 최고 유연 근무 프로그램의 ‘2022년 우수상’ 최종 후보로 선정
Monday, July 25, 2022
Novotech 的灵活工作政策入围最佳工作场所灵活性计划“2022 年卓越奖”
Novotech 的靈活工作政策入圍最佳工作場所靈活性計劃“2022 年卓越獎”
Novotech's Flexible Work Policy is Finalist in Best Workplace Flexibility Program "Excellence Award 2022"
Tuesday, July 19, 2022
노보텍과 엔드포인트, “중국의 세포 및 유전자 치료의 진화: 범용성 CAR-T 사례”에 관해 발표
Novotech和Endpoints展示“中国细胞和基因治疗的演变:通用CAR-T的案例”
Novotech和Endpoints展示“中國細胞和基因治療的演變:通用CAR-T的案例”
Monday, July 18, 2022
Novotech and Endpoints Present "Evolution of Cell & Gene Therapy in China: The Case for Universal CAR-T"
Thursday, July 14, 2022
노보텍 고객사 SK바이오사이언스, 스카이코비원(SKYCovione(TM)) 코로나19 백신 국내 승인
Novotech 客户 SK bioscience 在韩国获得 SKYCovione(TM) COVID-19 疫苗批准

Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575